Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)

NCT00518570 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Premenstrual Dysphoric Disorder

Interventions

DRUG: Levetiracetam

Sponsor

Berkshire Health Systems

Collaborators

[object Object]